Cancer Causes & Control

, Volume 9, Issue 6, pp 559–566 | Cite as

Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)

  • June M. Chan
  • Edward Giovannucci
  • Swen-Olof Andersson
  • Jonathan Yuen
  • Hans-Olov Adami
  • Alicja Wolk


Objectives: Dairy products consistently have been associated with an increased risk of prostate cancer, yet the mechanism of this relationship remains unknown. Recent hypotheses propose that 1,25 dihydroxyvitamin D (1,25 D) is protective for prostate cancer. One study in the United States found that calcium consumption, which can lower circulating 1,25 D, was associated with higher risk of advanced prostate cancer, and we sought to address this hypothesis in a distinct population.

Methods: We analyzed data from a population-based case- control study of prostate cancer conducted in Örebro, Sweden, with 526 cases and 536 controls. Using unconditional logistic regression models, we examined the relationship of dairy products, dietary calcium, phosphorous, and vitamin D with risk of total, extraprostatic, and metastatic prostate cancer.

Results: Calcium intake was an independent predictor of prostate cancer (relative risk (RR)=1.91, 95 percent confidence interval (CI) 1.23-2.97 for intake ≥1183 vs. <825mg/day), especially for metastatic tumors (RR=2.64, 95 percent CI 1.24-5.61), controlling for age, family history of prostate cancer, smoking, and total energy and phosphorous intakes. High consumption of dairy products was associated with a 50 percent increased risk of prostate cancer.

Conclusions: Our results support the hypothesis that high calcium intake may increase risk of prostate cancer, and this relation may underlie previously observed associations between dairy products and prostate cancer.

Calcium dairy phosphorous prostate cancer vitamin D 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Cancer Society. Cancer facts and figures. American Cancer Society, Inc., Atlanta, GA, 1996.Google Scholar
  2. 2.
    International Agency for Research on Cancer. Cancer Incidence in Five Continents, Vol VI (Parkin DM, Muir CS, Whelan SL, Gao, YT, Ferlay J, Powell, J, eds.) IARC Scientific Publications No. 120. World Health Organization, Lyon, 1992: International Agency for Research on Cancer and International Association of Cancer Registries.Google Scholar
  3. 3.
    Giovannucci E. Epidemiologic characteristics of prostate cancer. Cancer 1995; 75 (suppl): 1766–77.Google Scholar
  4. 4.
    Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7: 83–94.Google Scholar
  5. 5.
    Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85: 1571–9.Google Scholar
  6. 6.
    Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci E, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994; 86: 281–6.Google Scholar
  7. 7.
    Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 1995; 6: 145–54.Google Scholar
  8. 8.
    Mettlin C, Selenskas S, Natarajan NS, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk: A case-control study. Cancer 1989; 64: 605–12.Google Scholar
  9. 9.
    Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989; 64: 598–604.Google Scholar
  10. 10.
    Walker ARP, Walker BF, Tsotetsi NG, Sebitso C, Siwedi D, Walker AJ. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992; 65: 438–41.Google Scholar
  11. 11.
    Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49: 1857–60.Google Scholar
  12. 12.
    West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 1991; 2: 85–94.Google Scholar
  13. 13.
    Talamini R, La Vecchia C, Decarli A, Negri E, Franceschi S. Nutrition, social factors, and prostatic cancer in a Northern Italian population. Br J Cancer 1986; 53: 817–21.Google Scholar
  14. 14.
    Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984; 120: 244–50.Google Scholar
  15. 15.
    Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994; 5: 276–82.Google Scholar
  16. 16.
    Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983; 70: 687–92.Google Scholar
  17. 17.
    Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652–61.Google Scholar
  18. 18.
    Andersson S-O, Wolk A, Bergström R, et al. Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 1996; 68: 716–22.Google Scholar
  19. 19.
    Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998; 58: 442–7.Google Scholar
  20. 20.
    Lee MM, Wang R-T, Hsing AW, Gu F-L, Wang T, Spitz M. Case-control study of diet and prostate cancer in China. Cancer Causes Control 1998; 9: 545–52.Google Scholar
  21. 21.
    Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer 1992; 70: 2861–9.Google Scholar
  22. 22.
    Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166–70.Google Scholar
  23. 23.
    Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995; 6: 235–39.Google Scholar
  24. 24.
    Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 1996; 5: 121–6.Google Scholar
  25. 25.
    Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 1993; 2: 467–72.Google Scholar
  26. 26.
    Corder EH, Friedman GD, Vogelman JH, Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev 1995; 4: 655–9.Google Scholar
  27. 27.
    Feldman D, Skowronski RJ, Peehl DM. Vitamin D and prostate cancer. Adv Exp Med Biol 1995; 375: 53–63.Google Scholar
  28. 28.
    Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10: 1307–11.Google Scholar
  29. 29.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR. 1,25-dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology 1995; 46: 365–9.Google Scholar
  30. 30.
    Schwartz GG, Oeler TA, Uskokovic MR, Bahnson RR. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res 1994; 14: 1077–81.Google Scholar
  31. 31.
    Skowronski RJ, Peehl DM, Feldman D. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132: 1952–60.Google Scholar
  32. 32.
    Berne RM, Levy MN. Chapter 51. Endocrine regulation of calcium and phosphate metabolism. In: Berne RM, Levy MN, eds. Physiology. 2nd ed. St. Louis: C.V. Mosby Co., 1988: 875–94.Google Scholar
  33. 33.
    Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO. Lifestyle factors and prostate cancer risk: A case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 1996; 5: 509–13.Google Scholar
  34. 34.
    Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown and Company, 1986.Google Scholar
  35. 35.
    Willett WC. Nutritional Epidemiology. New York, NY: Oxford University Press, 1990.Google Scholar
  36. 36.
    Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: A hypothesis. Cancer Causes Control 1998; 9: 567–82.Google Scholar
  37. 37.
    Khan N, Yang K, Newmark H, et al. Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containing four components of a western-style diet. Carcinogenesis 1994; 15: 2645–8.Google Scholar
  38. 38.
    Kawaura A, Tanida T, Sawada K, Oda M, Shimoyama T. Suppression of colonic carcinogenesis by vitamin D in rats. J Nutr Sci Vitaminol (Tokyo) 1992; Spec No: 331-2.Google Scholar
  39. 39.
    Newmark HL. Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol 1994; 364: 109–14.Google Scholar
  40. 40.
    Nomura AMY, Stemmermann GN, Lee J, et al. Serum vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control 1998; 9: 425–32.Google Scholar
  41. 41.
    Linder MC, ed. Nutritional Biochemistry and Metabolism with Clinical Applications. New York: Elsevier, 1985.Google Scholar
  42. 42.
    Mezzanotte G, Cislaghi C, Decarli A, Le Vecchia C. Cancer mortality in broad Italian geographical areas, 1975-1977. Tumori 1986; 72: 145–52.Google Scholar
  43. 43.
    Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 58: 2263–71.Google Scholar
  44. 44.
    Giovannucci E. How is individual risk for prostate cancer assessed? Hematol Oncol Clin North Am 1996; 10: 537–48.Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • June M. Chan
    • 1
  • Edward Giovannucci
    • 2
    • 3
  • Swen-Olof Andersson
    • 4
    • 5
  • Jonathan Yuen
    • 6
  • Hans-Olov Adami
    • 1
    • 4
  • Alicja Wolk
    • 4
  1. 1.Department of EpidemiologyHarvard School of Public HealthBostonUSA
  2. 2.Channing Laboratory, Department of MedicineHarvard Medical SchoolBostonUSA
  3. 3.Department of NutritionHarvard School of Public HealthBostonUSA
  4. 4.Department of Medical EpidemiologyKarolinska InstituteStockholmSweden
  5. 5.Department of UrologyÖrebro Medical CenterÖrebroSweden
  6. 6.Department of Cancer EpidemiologyUppsala UniversityUppsalaSweden

Personalised recommendations